TABLE 4.
Interacting medication | Severity of DDI | Frequency of DDIs | Rate of DDIs (%) |
---|---|---|---|
Ondansetron | Contraindicated | 212 | 54.9 |
Lorazepam | Moderate | 165 | 42.7 |
Promethazine | Major | 120 | 31.1 |
Ciprofloxacin | Major | 113 | 29.3 |
Prochlorperazine | Major | 105 | 27.2 |
Esomeprazole | Major | 83 | 21.5 |
Fentanyl | Major | 80 | 20.7 |
Pantoprazole | Moderate | 80 | 20.7 |
Levofloxacin | Major | 67 | 17.4 |
Midazolam | Major | 67 | 17.4 |
Lansoprazole | Moderate | 56 | 14.5 |
Tacrolimus | Contraindicated | 49 | 12.7 |
Amlodipine | Moderate | 48 | 12.4 |
Fluconazole | Major | 46 | 11.9 |
Sirolimus | Contraindicated | 28 | 7.3 |
Alprazolam | Major | 24 | 6.2 |
Metoclopramide | Moderate | 24 | 6.2 |
Simvastatin | Contraindicated | 20 | 5.2 |
Azithromycin | Major | 18 | 4.7 |
Tamsulosin | Major | 18 | 4.7 |
Escitalopram | Contraindicated | 16 | 4.1 |
Haloperidol | Contraindicated | 16 | 4.1 |
Moxifloxacin | Major | 15 | 3.9 |
Warfarin | Major | 13 | 3.4 |
Cyclosporine | Major | 12 | 3.1 |
Data are for 386 posaconazole-treated patients with DDIs.